250 related articles for article (PubMed ID: 30615537)
1. Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma.
Bais MV
J Dent Res; 2019 Mar; 98(3):268-276. PubMed ID: 30615537
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers.
Dorna D; Paluszczak J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326475
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma.
Murali M; Saloura V
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360250
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.
Suchanti S; Stephen BJ; Awasthi S; Awasthi SK; Singh G; Singh A; Mishra R
Epigenomics; 2022 Mar; 14(5):279-293. PubMed ID: 35184601
[TBL] [Abstract][Full Text] [Related]
5. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
6. Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma.
Bottner J; Ribbat-Idel J; Klapper L; Jagomast T; Lemster AL; Perner S; Idel C; Kirfel J
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563463
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
Bourguignon LY; Wong G; Shiina M
J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
[TBL] [Abstract][Full Text] [Related]
8. microRNA-17 is a tumor suppressor in oral squamous cell carcinoma and is repressed by LSD1.
Wangzhou K; Fu W; Li M; Lu Z; Lai Z; Liu C; Tan Y; Hao C
Oral Dis; 2023 Mar; 29(2):491-504. PubMed ID: 34152066
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma.
Li KC; Hua KT; Lin YS; Su CY; Ko JY; Hsiao M; Kuo ML; Tan CT
Mol Cancer; 2014 Jul; 13():172. PubMed ID: 25027955
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
Bayo J; Fiore EJ; Dominguez LM; Real A; Malvicini M; Rizzo M; Atorrasagasti C; García MG; Argemi J; Martinez ED; Mazzolini GD
J Hepatol; 2019 Jul; 71(1):78-90. PubMed ID: 30880225
[TBL] [Abstract][Full Text] [Related]
11. Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1.
Zhang W; Cheng J; Diao P; Wang D; Zhang W; Jiang H; Wang Y
Br J Cancer; 2020 Feb; 122(4):528-538. PubMed ID: 31848446
[TBL] [Abstract][Full Text] [Related]
12. Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.
Starska-Kowarska K
Nutrients; 2023 May; 15(11):. PubMed ID: 37299554
[TBL] [Abstract][Full Text] [Related]
13. KDM5D Histone Demethylase Identifies Platinum-Tolerant Head and Neck Cancer Cells Vulnerable to Mitotic Catastrophe.
Chen TM; Huang CM; Setiawan SA; Hsieh MS; Sheen CC; Yeh CT
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982384
[TBL] [Abstract][Full Text] [Related]
14. The histone demethylase LSD1 is a novel oncogene and therapeutic target in oral cancer.
Wang Y; Zhu Y; Wang Q; Hu H; Li Z; Wang D; Zhang W; Qi B; Ye J; Wu H; Jiang H; Liu L; Yang J; Cheng J
Cancer Lett; 2016 Apr; 374(1):12-21. PubMed ID: 26872725
[TBL] [Abstract][Full Text] [Related]
15. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.
Gelato KA; Adler D; Ocker M; Haendler B
Expert Opin Ther Targets; 2016 Jul; 20(7):783-99. PubMed ID: 26799480
[TBL] [Abstract][Full Text] [Related]
16. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV
Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900
[TBL] [Abstract][Full Text] [Related]
17. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
[TBL] [Abstract][Full Text] [Related]
19. Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade.
Han Y; Xu S; Ye W; Wang Y; Zhang X; Deng J; Zhang Z; Liu L; Liu S
Cell Death Dis; 2021 Oct; 12(11):993. PubMed ID: 34689153
[TBL] [Abstract][Full Text] [Related]
20. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
Caeiro LD; Nakata Y; Borges RL; Zha M; Garcia-Martinez L; Bañuelos CP; Stransky S; Liu T; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar Benitah S; Cimmino L; Bilbao D; Sidoli S; Wang Z; Verdun RE; Morey L
Genes Dev; 2024 Feb; 38(1-2):46-69. PubMed ID: 38286657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
